Profound Medical (PROF) 6-K Titan Partners Group LLC, a division of American Capital Partners, LLC

 UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2023

Commission File Number: 001-39032

PROFOUND MEDICAL CORP.

(Translation of the registrant’s name into English)

2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ¨ Form 40-F x

Exhibit 99.1 of this Form 6-K of Profound Medical Corp. (the “Company”) is hereby incorporated by reference into the Registration Statement on Form F-10 (File No. 333-263248) of the Company, as amended or supplemented.

The following documents, which are attached as exhibits hereto, are incorporated by reference herein:

Exhibit	Title
99.1	Underwriting Agreement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	PROFOUND MEDICAL CORP.
	(Registrant)
Date: December 28, 2023	/s/ Rashed Dewan
	Rashed Dewan
	Chief Financial Officer